1 – 10 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
REACtiVe-2 : phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer
- Contribution to journal › Article
- 2024
-
Mark
Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC) : 5-Year Results of a Randomized Multicenter Trial
(2024) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42(2). p.140-145
- Contribution to journal › Article
- 2022
-
Mark
Behandling af peritoneale metastaser fra kolorektal cancer
- Contribution to specialist publication or newspaper › Specialist publication article
- 2021
-
Mark
Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer : study protocol of a multicentre, open-label, parallel-arms, randomized controlled study (PelvEx II)
- Contribution to journal › Article
-
Mark
Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance
- Contribution to journal › Article
- 2019
-
Mark
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC) : a multicentre, open-label, randomised trial
- Contribution to journal › Article
- 2018
-
Mark
Effects of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Goblet Cell Carcinoma : A Prospective Cohort Study
- Contribution to journal › Article
-
Mark
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
- Contribution to journal › Article
- 2016
-
Mark
Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer
- Contribution to journal › Article
-
Mark
Challenging the dogma of colorectal peritoneal metastases as an untreatable condition : Results of a population-based study
- Contribution to journal › Article
